Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
. —Meanwhile, check out reports here , here , and here for some of the other headlines coming out of ASCO, including progress made in cancer immunotherapy, the ups and downs from various presenting companies, and a visit from Vice President Joe Biden. Ed Silverman at STAT reported the analyst note first.
67 
Let's personalize your content